Kathleen S. Wright Associates Inc. Pds Biotechnology Corp Transaction History
Kathleen S. Wright Associates Inc.
- $242 Million
- Q4 2024
A detailed history of Kathleen S. Wright Associates Inc. transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Kathleen S. Wright Associates Inc. holds 7,000 shares of PDSB stock, worth $10,570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,000
Previous 7,000
-0.0%
Holding current value
$10,570
Previous $26,000
57.69%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
65Shares Held
4.05MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$2.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$735,3200.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$626,8200.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$353,6550.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA134KShares$202,7320.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $43M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...